Bookings for this event are closed.
If the event is Optometry Tomorrow, Optometry Tomorrow Bitesize, the Diploma Ceremony or a regional member CET event you can call 020 7766 4377/4347 to see if there are any spaces.
If the event is a webinar on online peer discussion please call 020 7766 4361 or email email@example.com.×
News from sponsors
This page will be regularly updated with news from our sponsors - be sure to check back to see what's in store at the event!
2019 sees Thea Pharmaceuticals launch a brand new eye care product in the UK as well as continuing to provide unique, high quality education and innovative preservative free products including ranges designed to help alleviate Dry Eye, Blepharitis and Meibomian Gland Dysfunction, along with a range of Eye Nutritionals to support eye health and help to protect vision.
We are very pleased to be able to support the agenda at Optometry Tomorrow this year with two thought-provoking lectures which will be repeated on both days. These lectures should provide brilliant insight into treatment of different eye health conditions. If you have any questions after the talks please come and see us on the Thea stand
Sarah Farrant will be presenting ‘What’s all the fuss about Demodex?’ a talk which clarifies exactly what Demodex is, untangles the myths and mysteries about the mites and highlights what products should be used to treat them.
Iain Johnson will also be providing an intriguing session discussing how thinking like an engineer might help you give the right advice to your patients who need treatment from the symptoms of Dry Eye and Blepharitis.
For more information on our products, training and literature packages please come and see us on our stand at the main entrance, visit our website www.thea-pharmaceuticals.co.uk
Johnson & Johnson Vision
At Johnson & Johnson Vision, we have a bold ambition: to change the trajectory of eye health around the world. We deliver innovative vision solutions that enable Eye Care Professionals to create better outcomes for their patients throughout their lives; from sight correction solutions including world leading surgical technologies and contact lenses, to dry eye diagnosis, treatment and management and the restoration of vision for cataract patients. Since debuting the world’s first disposable soft contact lens in 1987, we have been helping patients see better through our world-leading portfolio of ACUVUE® Brand Contact Lenses. Serving more than 60 million patients a day across 103 countries, we are committed to helping people see better, connect better and live better.
Supporting further education for eye care professionals is key in making this commitment a reality. Johnson & Johnson Vision is delighted to once again be a Gold Sponsor of Optometry Tomorrow and bring you two interactive discussion workshops: ‘Getting it right with generation Z’ and ‘One hour, 10 patients. Are you up for the challenge?’. Book your place now.
We look forward to welcoming you at the Johnson & Johnson Vision stand at Optometry Tomorrow 2019. For more information on our services and products please visit www.jnjvisioncare.co.uk
Visioneering Technologies, Inc (VTI)
Visioneering Technologies, Inc. (VTI), located in Atlanta, Georgia, USA, is an innovative company developing products that redefine vision for presbyopia, myopia and astigmatism. The company uses creative and differentiated approaches to develop products that are designed to enhance practitioner and patient experiences. Visit www.vtivision.com for more information.
In 2018 VTI announced receipt of the European CE Mark (Conformité Européenne) for commercialization in the European Union of its portfolio of proprietary NaturalVue® (etafilcon A) brand 1 Day Contact Lenses, including Sphere, Toric, Multifocal and Multifocal Toric.
VTI’s CE Mark includes an indication for VTI’s unique NaturalVue® Multifocal (NVMF) contact lenses for myopic progression control (the control of progressive nearsightedness). NVMF contact lenses feature VTI’s innovative Neurofocus Optics® Technology, which employs a patented extended depth-of-focus design to address known optical risk factors associated with myopia progression. The innovative NVMF lens design allows it to be used for both myopic progression control and presbyopia (the age-related loss of ability to see near objects).
Essilor teams worldwide are driven by the vital mission of Improving lives by Improving sight and work alongside partners, supporting non-profit initiatives so that we can help the third of the global population with uncorrected poor vision to see well and live well. Essilor operates in 70 countries worldwide and employs 67,000 people.
From The Centre of Excellence in Thornbury near Bristol, Essilor Ltd offers a global service at a local level. The local laboratory manufactures highly innovative products such as Varilux X series and Eyecode lenses and the business has received accreditation from the Institute of Customer Service for seven consecutive years. Essilor Ltd employs 370 people who are based throughout the UK.
Essilor has also been ranked on Forbes magazine’s 'Most Innovative Companies' list for a fifth year in a row. We believe it is essential for us to continue innovating and do this by investing £170 million worldwide into R&D. By enriching all levels of our product range we provide effective solutions to independent opticians to address evolving patient needs.
We work closely with all our Opticians providing not only lenses and equipment but also strategic business advice in sales, marketing and customer support, helping them to grow their businesses.
Since 1945 Alcon® has been working to enhance quality of life by helping people see better. Alcon® is a global leader in eye care and is comprised of two business units – Vision Care and Surgical. Alcon® offer the widest spectrum of eye care products in the world: From a comprehensive portfolio of contact lenses and lens care products to the most complete line of ophthalmic surgical products.
We offer products that improve patients’ vision and match today’s active lifestyles and demands. The Alcon® product portfolio comprises:
• DAILIES® disposable contact lenses, including DAILIES TOTAL1® (the first water gradient contact lens), AOP Product of the Year DAILIES TOTAL1® Multifocal, and DAILIES® AquaComfort Plus® family of contact lenses
• AIR OPTIX® contact lenses, including AIR OPTIX® plus HydraGlyde® and AIR OPTIX® plus HydraGlyde Multifocal
• FreshLook® colour contact lenses
• Lens care products which include OPTI-FREE® PureMoist® multi-purpose disinfecting solution and AOSEPT® PLUS with HydraGlyde®
• The SYSTANE® eye drop family, including SYSTANE® HYDRATION, offers long-lasting dry eye relief through corneal surface restoration.
From high oxygen transmissibility to highly innovative wetting technologies, Alcon® Vision Care continues to set new standards, advancing the science of contact lenses, lens care and state-of-the art manufacturing.
Please visit us at our stand or at www.myalcon.co.uk for more details.
AVIZOR have been manufacturing Eye Care Solutions for over 35 years with Contact Lens Care Solutions and Ocular Health products.
We have seen a massive growth in our range of Contact Lens Solutions, for example EverClean Preservative Free One Step Solution for use with soft, rigid and Ortho K contact lenses, also GP Multi provides one of the best options for 1 step cleaning and disinfecting Rigid GP and Ortho K lenses. Our flagship brand for soft lenses is Alvera a UNIQUE solution that contains Aloe Vera. We have gained a patent on ‘Eye Cell Protection’ as Alvera helps prevent cell damage and is perfect for sensitive eyes.
The Lacrifresh Ocular Health range is with out doubt one of the big talking points in the industry as we offer a range of products from the new Aloe with Aloe Vera for Eye Irritations to Ocu-Dry 0.20% & 0.30% (hyaluronate). 0.30% is Hypotonic and has the lowest Osmolarity in the range at only 190 mOsm/L. A viscosity range of 48-42 cP ensures coverage of the surface of the eye, providing prolonged relief of moderate - severe dry eye symptoms.
For more information visit AVIZOR at the 2019 Optometry Tomorrow Conference.